跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 13 条关于
“zbco”
全部
13
临床试验
2
药物
2
机构
1
资讯
8
去年
FDA Approves Bizengri (zenocutuzumab-zbco) for NRG1+ Pancreatic and Non-Small Cell Lung Cancers
9个月前
Zenocutuzumab Shows Superior Efficacy in Treatment-Naïve NRG1+ NSCLC Patients
去年
FDA Approves Bizengri for NRG1 Fusion-Positive Lung and Pancreatic Cancers
去年
Precision Medicine Takes Center Stage at SOGO 2025: New Frontiers in GI Cancer Treatment
去年
FDA Approves First Systemic Therapy for NRG1 Fusion-Positive Cancers and MSC Therapy for SR-aGVHD
11个月前
Zenocutuzumab Shows 37% Response Rate in Rare NRG1-Positive Cholangiocarcinoma
去年
Diaceutics Secures £11.5M Contract with Partner Therapeutics to Commercialize Oncology Precision Medicine BIZENGRI
去年
Pancreatic Cancer: Advances in Treatment and Research Bring Hope in 2024